Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Deloitte
Accenture
UBS
Argus Health

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 10,086,046

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,086,046
Title:Agent for the treatment and or prophylaxis of an autoimmune disease and for the formation of regulatory T cells
Abstract: The present invention relates to an agent for the treatment and/or prophylaxis of an autoimmune disease, an agent for the formation of regulatory T cells (T.sub.Reg) in an organism and various methods in which the agents according to the invention are used.
Inventor(s): Paulsen; Daniela (Wuppertal, DE), Brunner; Nina (Essen, DE), Bray; Dorothy (Buckinghamshire, GB)
Assignee: AiCuris GmbH & Co. KG (Wuppertal, DE)
Application Number:15/439,845
Patent Claims:see list of patent claims

Details for Patent 10,086,046

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 001 1998-05-12   Try a Free Trial AiCuris GmbH & Co. KG (Wuppertal, DE) 2028-05-08 RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12   Try a Free Trial AiCuris GmbH & Co. KG (Wuppertal, DE) 2028-05-08 RX search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Try a Free Trial AiCuris GmbH & Co. KG (Wuppertal, DE) 2028-05-08 RX Orphan search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31   Try a Free Trial AiCuris GmbH & Co. KG (Wuppertal, DE) 2028-05-08 RX search
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31   Try a Free Trial AiCuris GmbH & Co. KG (Wuppertal, DE) 2028-05-08 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Colorcon
Accenture
Covington
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.